Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees

This article was originally published in The Gray Sheet

Executive Summary

The tentative agreement of $595 million in user fees over five years is more than companies had wanted to spend. But industry negotiators insist it is a good deal, tied to performance goals and process improvements they say will ensure greater speed and predictability in reaching the U.S. market.

Advertisement

Related Content

Cepheid Flu Test Wins First CLIA Waiver For PCR Panel
Industry Challenges FDA's User Fee Markup
Device Reg Issues In Play As FDA Kicks Off User Fee Renewal Effort
Chatting With FDA: New Draft Guidance Addresses Communications During Device Reviews
Device Trends To Watch In 2013
The Medical Device Industry Stays The Course In 2012
Washington Roundup, November-December 2012
CDRH In 2012: More Pilots, Guidances And Regs
FDA, Industry Haggle Over Price For New User Fee Deal
FDA Embraces Total-Time Pre-Market Review Goals, With Shared Accountability

Topics

Advertisement
UsernamePublicRestriction

Register

MT030934

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel